IGF2BP3 and head and neck cancer: 3.7. Upregulated m6A-RMRs Were More Than Downregulated m6A-RMRs in Various Cancer Types; Head and Neck Cancer, Cervical Cancer, Brain and CNS Cancer, Other Cancer, and Kidney Cancer Upregulated ≥10 m6A-RMRs; and IGF2BP3, G3BP1, IGF2BP2, and HNRNPC Were Upregulated in ≥10 Cancer Types